SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-021490
Filing Date
2022-06-01
Accepted
2022-06-01 17:00:13
Documents
2
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 3419
2 EXHIBIT 24.1 brhc10038382_ex24-1.htm EX-24.1 10763
  Complete submission text file 0001140361-22-021490.txt   15866
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10531 4S COMMONS DRIVE SUITE 160-550 SAN DIEGO CA 92127
Business Address
Angel Matthew (Reporting) CIK: 0001931356 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 22988129